InvestorsHub Logo
Followers 36
Posts 4481
Boards Moderated 0
Alias Born 01/29/2010

Re: None

Wednesday, 05/03/2017 12:59:09 PM

Wednesday, May 03, 2017 12:59:09 PM

Post# of 97093
SA article from 4/6/17 4 Companies That Stand to Benefit from Lower Healthcare Prices

"DECN now has a chance to succeed simply because the market for glucose monitoring strips is so large. Even a 1% worldwide market share would yield nearly a hundred million in annual gross revenue (50 test strips cost about $16 to $18). And the annual market for glucose test strips is growing thanks to the U.S. obesity epidemic. The point of care diagnostic industry is expected to grow to nearly $40 billion by 2021. Diabetes management via glucose monitoring diagnostics industry market has reached nearly $10 billion per year. DECN strips are compatible with the industry standard diagnostic equipment, even monitors made by Johnson & Johnson. One would expect any equivalent product at a lower price to gain market share, and DECN claims to have a superior product as well as being less expensive. The company stated on December 1, 2016, that it has ramped up its marketing, manufacturing, and distribution efforts after having gained legal grounds to execute its business plan. One should monitor company sales before investing in this high risk situation."

Full Article: https://seekingalpha.com/article/4060752-4-companies-stand-benefit-lower-healthcare-prices